INSIGHTS ON LIQUID DOSE MANUFACTURING

• Barrel Filling Vs. Tip Filling A Syringe – Which Approach Should Be Used?

  There are two primary filling methods for pre-filled syringes. Explore the pros and cons of each approach, highlighting why barrel filling is generally preferred in the pharmaceutical industry.

• Stability Issues Unique To Liquid Injectables And How To Avoid Them

  Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.

• ADC Drug Products: Solutions To Manage Risks And Enhance Stability

  Discover how an integrated ADC strategy addresses containment, analytics, fill-finish, and inspection challenges to improve product protection, process reliability, and delivery performance.

• Cost-Effective Strategies For Sterile Injectable Outsourcing

  Explore how CMOs are playing a pivotal role in enabling pharmaceutical companies to optimize their operations and how this collaboration is reshaping the future of pharmaceutical manufacturing.

• Cutting Through Complexity: An Integrated Model For Faster PFS Development

  4/7/2026

  Discover how integrated, end-to-end development for prefilled syringes can streamline timelines, enhance patient-centric delivery, and scale efficiently from early development to global launch.

• How Do We Reduce Your Environmental Cost Of Ownership (ECO)?

  12/4/2025

  By rethinking cleanroom requirements and reducing resource-heavy sterilization steps, manufacturers can significantly lower their Environmental Cost of Ownership and futureproof their operations.

• Still Pipette-Filling Cryovials? There's A Better Way

  7/7/2025

  Manual cryovial filling in cell therapy is risky, time-consuming, and unsustainable. Learn why automating this crucial step is essential for precision, viability, and scalability.

• Spray Dried Biologics For Injectable Dosage Forms

  5/15/2026

  Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.

• 0.45 m/s ±20% At Working Position In Closed Sterility Testing Isolators: Requirement Or Convention?

  2/19/2026

  Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.